Visceral leishmaniasis associated with ixekizumab therapy presenting as hemophagocytic lymphohistiocytosis
Medicina Clínica
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Cite
Get new articles on “General Medicine”
Subscriptions, keyword tracking and favourites — in the Articlium Telegram bot.
Open in Telegram
Citation
✕
ГОСТ
APA
MLA
BibTeX
Visceral leishmaniasis associated with ixekizumab therapy presenting as hemophagocytic lymphohistiocytosis. // Medicina Clínica. – URL: https://www.sciencedirect.com/science/article/pii/S0025775326003349?dgcid=rss_sd_all
Visceral leishmaniasis associated with ixekizumab therapy presenting as hemophagocytic lymphohistiocytosis. Medicina Clínica. https://www.sciencedirect.com/science/article/pii/S0025775326003349?dgcid=rss_sd_all
“Visceral leishmaniasis associated with ixekizumab therapy presenting as hemophagocytic lymphohistiocytosis.” Medicina Clínica.
@article{article117337,
title = {Visceral leishmaniasis associated with ixekizumab therapy presenting as hemophagocytic lymphohistiocytosis},
journal = {Medicina Clínica},
url = {https://www.sciencedirect.com/science/article/pii/S0025775326003349?dgcid=rss_sd_all}
}